Description: Cilostazol, also known as Pletal, is a selective inhibitor of type III phosphodiesterase (PDE-III), a cyclic nucleotide-specific enzyme that degrades cAMP (adenosine monophosphate). Inhibiting this enzyme increases cAMP levels, which increases blood flow. Cilostazol can improve blood flow in patients with peripheral vascular disease.
Note: All these medications should be taken under doctor's supervision.
To continue providing the latest and most unique DCGI approved formulations, all across the globe, we are actively inviting PCD Pharma Franchise for unrepresented areas. We believe in “dare to be first” philosophy, as well as innovation and persistence. Our philosophy can only be achieved with your continuous participation and business.